ASO Visual Abstract: The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma: An Australian Cohort
Ann Surg Oncol
.
2024 May 17.
doi: 10.1245/s10434-024-15348-z.
Online ahead of print.
Authors
Lisanne P Zijlker
1
2
3
,
Henry Chen
4
,
Andrew J Spillane
3
4
5
6
,
Maria Gonzalez
3
,
Thomas E Pennington
3
4
7
,
Alexander M Menzies
3
4
5
6
,
Serigne N Lo
3
4
,
Peter Ferguson
3
4
7
8
,
Robert Rawson
3
4
7
8
,
Andrew J Colebatch
3
4
7
8
,
Jonathan R Stretch
3
4
7
,
John F Thompson
3
4
6
7
,
Sydney Ch'ng
3
4
7
,
Omgo Nieweg
3
6
7
,
Kerwin F Shannon
3
4
7
,
Georgina V Long
3
4
5
6
,
Richard A Scolyer
3
4
7
8
9
,
Robyn P M Saw
3
4
7
,
Alexander C J van Akkooi
10
11
12
Affiliations
1
Netherlands Cancer Institute-Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, The Netherlands.
2
Leiden University Medical Center, Leiden, The Netherlands.
3
Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
4
Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
5
Royal North Shore Hospital, Sydney, NSW, Australia.
6
The Mater Hospital, Sydney, NSW, Australia.
7
Royal Prince Alfred Hospital, Sydney, NSW, Australia.
8
NSW Health Pathology, Sydney, NSW, Australia.
9
Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.
10
Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. alexander.vanakkooi@melanoma.org.au.
11
Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. alexander.vanakkooi@melanoma.org.au.
12
Royal Prince Alfred Hospital, Sydney, NSW, Australia. alexander.vanakkooi@melanoma.org.au.
PMID:
38758487
DOI:
10.1245/s10434-024-15348-z
No abstract available